Nurse Practitioner in Walker, MN Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Ms. Rachel Diane Erickson, APRN, CNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 110 Michigan Ave W, Walker, MN 56484 Phone: 218-547-3452 |
Kelsey R Stay, APRN,CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 110 Michigan Ave W, Walker, MN 56484 Phone: 218-547-3452 |
Tamera Lyn Mahaffey, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 614 Michigan Ave W, Walker, MN 56484 Phone: 218-547-7700 |
Ms. Katherine Marie Miller, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 614 Michigan Ave W, Walker, MN 56484 Phone: 218-547-7700 |
News Archive
Children exposed to intimate partner violence from infancy were twice as likely to have poor health
A new study has found up to half of all children with language difficulties and mental and physical health problems have been exposed to intimate partner violence, prompting calls for health and social care services to provide more effective identification and early intervention.
New oral blood thinner
A new oral blood thinner is being compared to an old standby to see if it works as well and is easier to manage long term, researchers say.
Vitamin A insufficiency linked to hand, foot and mouth disease
Vitamin A status is associated with immunity to, and pathogenic condition of, hand, foot, and mouth disease in children, say researchers whose study results show that the majority of those with the infectious disease also had vitamin A insufficiency.
Genetically engineered blood protein can be used to split water into oxygen and hydrogen
Scientists have combined two molecules that occur naturally in blood to engineer a molecular complex that uses solar energy to split water into hydrogen and oxygen, says research published in the Journal of the American Chemical Society.
GSK reports 45% survival rate in phase III study of Tafinlar in BRAF V600E mutant metastatic melanoma
GSK today announced updated results for Tafinlar (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.
› Verified 1 days ago